Ductal carcinoma in situ
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Women 18 years and older with DCIS less than 2 cm in diameter 2 Patients signed an informed consent form before participating in this study. 3 Patient who can get an MRI
Exclusion criteria
Exclusion criteria: 1 Metallic implants or other incompatibility with MRI 2 Pregnant or lactating patients 3 Patients not to endure this treatment 4 Patients who are'nt eligible for this study by other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Completely coagulation necrosis of tumor using histopathological methods. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 adverse events 2 cosmetically assessment 3 the amount of cfDNA in plasma before and after treatment 4 non palpable lesion become palpable post treatment 5 negative margin of surgical specimen 6 no residual cancer cell in biopsy specimen before treatment | — |
Countries
Japan
Contacts
Showa university Breast surgery